Are transversal MR images sufficient to distinguish persons with mild cognitive impairment from healthy controls?

Christoph Mönninghoff1, Martha Dlugaj2, Oliver Kraff3

  • 1Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Academic Radiology
|July 12, 2015
PubMed
Abstract

Insights

Standard MRI markers like white matter hyperintensities and brain atrophy can help distinguish amnestic mild cognitive impairment (aMCI) from nonamnestic MCI and healthy controls. These findings aid in early diagnosis and dementia risk assessment.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Mild cognitive impairment (MCI) increases dementia risk.
  • Distinguishing MCI subtypes is crucial for prognosis and treatment.
  • Standard MRI markers are being investigated for diagnostic utility.

Purpose of the Study:

  • To evaluate if standard MRI can differentiate amnestic MCI (aMCI), nonamnestic MCI (naMCI), and healthy controls (HCs).
  • To identify specific MRI markers associated with MCI subtypes.

Main Methods:

  • 126 MCI patients and 126 HCs underwent 1.5-T MRI.
  • White matter hyperintensities (WMHs), microbleeds, and brain atrophy were assessed by blinded neuroradiologists.
  • Logistic regression and ROC analysis were employed.

Main Results:

  • Increased occipital WMH burden was observed in aMCI versus HCs (P=.01).
  • Brain atrophy was noted in MCI patients, particularly at the caudate nuclei and temporal horns in aMCI.
  • Microbleeds were more frequent in aMCI than naMCI subjects.

Conclusions:

  • Occipital WMHs and specific brain atrophies distinguish aMCI from naMCI and HCs.
  • Volumetric MRI indices show diagnostic potential for MCI subtypes.
  • Reproducible assessment of volumetric indices is recommended for improved diagnostic accuracy.